Cannabis: Best 10-Year Growth Opportunity | Skin in the Game | Real Vision

TL;DR

The cannabis industry has the potential to become a multi-trillion dollar industry within 10 years, with various sectors like biopharmaceuticals, consumer packaged goods, and building materials being impacted. However, the government's resistance to fully embrace it poses a challenge.

Transcript

BP: And with that in mind with GW, with those $175 price targets, you think those are a little bit on the low end. That we could see a lot more movement when all of these factors get taken into account. TH: Oh, for sure. I mean, this is being-- we've spoken to the analysts. They're basing this on Epidiolex, which is going to be a terrific drug for ... Read More

Key Insights

• 😷 The cannabis industry's potential extends well beyond medical advancements, with various sectors like consumer packaged goods and building materials set to benefit.
• 🍉 The volatility in cannabis stocks is due to significant short-selling and short-term hype, but the long-term value lies in understanding the industry's potential.
• 🥳 Laboratories' role in extraction and biopharmaceutical developments should not be overlooked, as they form essential parts of the cannabis industry.
• 👁️‍🗨️ The global cannabis index's 40% decline indicates that the industry is still far from being overvalued or in a bubble.
• 🪛 The government's regulation and resistance, driven by financial interests, pose a challenge to the industry's growth and market valuation.
• 😑 The cannabis industry has gained traction globally, with countries like Australia, Germany, and Canada expressing interest in dominating the market.
• ❤️‍🩹 Cannabis and hemp have the potential to be ingredients in a wide range of end products, making the industry applicable to various sectors.

Questions & Answers

Q: What are the primary factors that analysts consider when valuing cannabis stocks?

Analysts often focus on medical advancements, specifically drugs like Epidiolex, which address seizures in children and epilepsy in adults. However, they fail to fully grasp the potential in other sectors, such as consumer packaged goods.

Q: How does the short-selling activity impact the cannabis industry?

The industry experiences significant short-selling activities, which contributes to heightened volatility in stock prices. While this may generate excitement and media attention, the actual value lies in understanding the industry's long-term potential beyond short-term fluctuations.

Q: What sectors within the cannabis industry have significant growth potential?

Cultivation and dispensaries are of interest, but it's essential to view large licensed producers (LPs) as biotech and consumer packaged goods companies. Laboratories, particularly for extraction, play a crucial role, and biopharmaceuticals are seen as the next phase of development.

Q: Why is there a mismatch between the market valuation of cannabis stocks and the projected industry size?

Currently, cannabis equities amount to around $60-70 billion, while the cannabis industry as a whole is estimated to be worth $2-3 trillion in 10 years. This discrepancy arises partly due to government resistance and the limited ways in which they profit from the industry.

Summary & Key Takeaways

• The stock prices of cannabis companies are currently undervalued, with potential for significant growth when considering the various factors affecting the industry.

• Analysts often focus on the medical potential of cannabis, particularly in the form of drugs like Epidiolex, but fail to grasp its efficacy in other sectors such as consumer packaged goods.

• The cannabis industry has experienced significant short-selling activities, leading to volatility in stock prices. However, despite the hype, the global cannabis index is still down 40% for the year.

• The industry encompasses various sectors of interest, including cultivation, dispensaries, laboratories (extraction), biopharmaceuticals, and others like building materials and clothing.